If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
NEUROLOGY
EMJ Neurol. 2017 Suppl 1 • europeanmedical-journal.com
INSIDE
New Developments
for Parkinson’s Therapy
with COMT Inhibitors
NEW DEVELOPMENTS FOR PARKINSON’S
THERAPY WITH COMT INHIBITORS
This symposium took place on 22nd September 2016 as a
part of the 89th Deutsche Gesellschaft für Neurologie (DGN)
Congress in Mannheim, Germany
Chairperson
Heinz Reichmann1
Speakers
Werner Poewe,2 Georg Ebersbach,3 Thomas Müller4
1. Universitätsklinikum Technische Universität Dresden, Dresden, Germany
2. Medizinische Universität Innsbruck, Innsbruck, Austria
3. Neurologisches Fachkrankenhaus für Bewegungsstörungen, Beelitz-Heilstätten, Germany
4. Alexianer St. Joseph Berlin-Weißensee, Berlin, Germany
Disclosure: Prof Heinz Reichmann receiv
NEUROLOGY EMJ Neurol. 2017 Suppl 1 • europeanmedi
NEW DEVELOPMENTS FOR PARKINSON’S THERAPY WI
those switching from combination treatment with e
More recent investigations led to the conclusion
However, their low effectiveness in tre
Investigator’s Global Assessment of Change (%) p
Levodopa-related ‘Wearing off’ in Parkinson’s D
125 75 25 -25 -75 LS mean change fro
Update: Treatments for the motor symptoms
Dyskinesia (LID) in Parkinson’s Disease Patients